Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TSN | ZBRA |
|---|---|---|
| Price | $50.31 | $376.79 |
| Change today | ▼ 0.44% | ▲ 0.93% |
| Market cap | $17.70B | $17.83B |
| Return, 3 months | -13.1% | +40.7% |
| Return, year to date | -12.0% | +55.2% |
| Return, 1 year | -4.4% | +29.1% |
| P/E (TTM) | 31.1 | 34.5 |
| P/B | 1.0 | 5.2 |
| P/E percentile vs own 5y | 77th | 66th |
| Dividend yield | 4.03% | – |
| Revenue growth (YoY, latest qtr) | -0.1% | +20.4% |
| Net profit growth (YoY) | +169.6% | +108.0% |
| Gross margin | 6.1% | 49.6% |
| Operating margin | 2.3% | 16.6% |
| Net margin | 1.0% | 9.2% |
| Return on equity | 3.2% | 15.3% |
| Analyst target vs. price | +30.1% | +4.8% |
| Analyst buy share | 71% | 64% |
| RSI (14) | 31 | 62 |
| 30-day volatility | 26.0% | 28.3% |
| Max drawdown, 1 year | -25.2% | -38.3% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
